Atlas Venture Fund X L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-15 4:56 pm Purchase |
2023-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH |
Atlas Venture Fund X L.P. | 186,089 1.300% |
186,089 (New Position) |
Filing |